Q: May I have your opinion on the latest Financial results released by the Andlauer Group. Thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Please comment on earnings, did management comment on plans for their cash horde in the call?
Regards greg
Regards greg
Q: Is there any upside potential for this company ? I am a long term investor with a high risk tolerance.
Q: What are your thoughts ? Thanks.
Q: With a new quarterly report and higher stock price, what do you think today of CARRX? Would you see owning both CRRX and WELL as a good decision on health care?
John
John
Q: What are your thoughts ? Thanks.
Q: Please comment on Knight's quarter released this morning. Thanks.
Q: Hi Peter. Your team's thoughts on Savaria - they just reported but looks like they missed the EPS expectations - explanation was inflationary pressure which looks like they are not able to pass off to customers - your thoughts on the performance and going forward...... thank you.
-
Welltower Inc. (WELL)
-
Ventas Inc. (VTR)
-
Chartwell Retirement Residences (CSH.UN)
-
Sienna Senior Living Inc. (SIA)
Q: what would be your top choices as an investment in the "senior homes" (residences) category for both Canada and the U.S.?
Q: I'm interested in investing in CAR T-Cell therapy, and these are a couple of the few I've located so far. May I have your thoughts? Are there any others you are aware of that you would prefer?
Q: Can you comment on earnings. How did they do compared to expectations? What do you see going forward? Would you complete a position at this time?
Q: Comments please on the latest quarter. Thanks.
Q: With the recent news about them having a unit to per form dialysis at home would this company be ok to invest small amount 125 shares US for future growth Tks 5i
Q: Cloud MD appears to have good growth according to some reports, but, the share price has kept going down. What is the outlook for this company in 2 to 3 years? Is the current price a hold, sell or buy?
Q: Good morning 5i,
I'd like to put some funds into healthcare for a what expect to be 3 to 5 years. Currently, HHL will provide around 8.6% per annum income, but capital gain potential seems limited. DHT.UN meanwhile is currently yielding 2.4% but the analysts I have access to appear optimistic for future share price growth.
I definitely like the HHL income (which I would reinvest in the name quarterly) but wonder if, in your opinion based on current available info, whether or not it would be overly risky to lock down some DHT.UN at current levels instead. I guess an earnings report or two from DHT.UN illustrating how 2021 has gone so far might be helpful in looking ahead, but I'm not aware of any ...?
Thanks for your thoughts.
Peter
I'd like to put some funds into healthcare for a what expect to be 3 to 5 years. Currently, HHL will provide around 8.6% per annum income, but capital gain potential seems limited. DHT.UN meanwhile is currently yielding 2.4% but the analysts I have access to appear optimistic for future share price growth.
I definitely like the HHL income (which I would reinvest in the name quarterly) but wonder if, in your opinion based on current available info, whether or not it would be overly risky to lock down some DHT.UN at current levels instead. I guess an earnings report or two from DHT.UN illustrating how 2021 has gone so far might be helpful in looking ahead, but I'm not aware of any ...?
Thanks for your thoughts.
Peter
Q: What are your thoughts on initiating a long term position in Guardant at these levels? Thanks
Q: Is there any news causing the 20% recent plunge in PRN?
Thank you
Thank you
Q: Since bottoming in Sept, this company has more than doubled its' stock price. Any reason why, and would you recommend it as a buy, sell or hold. Thank you.
Q: Trying to understand this stock. Sales are through the roof with vaccine but yet stock prices languishes. Why is this?
Q: Could I have your opinion on Charles River Labs post earnings and resulting 10 % decline .
Thank - you.
Thank - you.